The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALKERMES PLC | COM | G01767105 | 6,972 | 257,554 | SH | SOLE | 257,554 | 0 | 0 | |||
| BIOGEN INC | COM | 09062X103 | 28,909 | 134,068 | SH | SOLE | 134,068 | 0 | 0 | |||
| BIONTECH SE-ADR | COM | 09075V102 | 11,070 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | |||
| CARDINAL HEALTH INC | COM | 14149Y108 | 26,370 | 235,656 | SH | SOLE | 235,656 | 0 | 0 | |||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 19,635 | 1,124,586 | SH | SOLE | 1,124,586 | 0 | 0 | |||
| EXELIXIS INC | COM | 30161Q104 | 37,165 | 1,566,140 | SH | SOLE | 1,566,140 | 0 | 0 | |||
| JAZZ PHARMACEUTICALS PLC | COM | G50871105 | 12,181 | 101,151 | SH | SOLE | 101,151 | 0 | 0 | |||
| MURAL ONCOLOGY PLC | COM | G63365103 | 430 | 88,001 | SH | SOLE | 88,001 | 0 | 0 | |||
| REGENERON PHARMACEUTICALS | COM | 75886F107 | 12,025 | 12,494 | SH | SOLE | 12,494 | 0 | 0 | |||
| SANOFI-ADR | COM | 80105N105 | 7,337 | 150,959 | SH | SOLE | 150,959 | 0 | 0 | |||
| TARO PHARMACEUTICAL INDUS | COM | M8737E108 | 27,431 | 647,868 | SH | SOLE | 647,868 | 0 | 0 | |||
| UNITED THERAPEUTICS CORP | COM | 91307C102 | 36,000 | 156,714 | SH | SOLE | 156,714 | 0 | 0 | |||